Citation Impact
1 from Science/Nature 71 standout
Citing Papers
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
2024 Standout
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
2024 Standout
Works of A. Li being referenced
1311P First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA
2020
Randomized results of fixed-duration (1-yr) vs continuous nivolumab in patients (pts) with advanced non-small cell lung cancer (NSCLC)
2017
Author Peers
| Author | PRM | Oncology | Physiology | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| A. Li | 98 | 138 | 28 | 13 | 145 | ||
| Nola Purdie | 13 | 54 | 2.5k | ||||
| L Giannarini | 62 | 162 | 170 | 1068 | 8 | 1.5k | |
| Ken Borrelli | 2 | 20 | 3 | 10 | 5 | 275 | |
| S. Ohtake | 10 | 147 | |||||
| Peter Pratt | 2 | 2 | 2 | 7 | 276 |
All Works
Login with ORCID to disown or claim papers
Loading papers...